₹1,371.00
-29.65 (-2.12%)
As of 22 Sept 2026, Alivus Life Sciences Ltd share price is ₹1,371.00. The stock opened at ₹1,371.00 and had closed at ₹1,400.65 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹830.00 and a high of ₹1,495.30. In terms of performance, Alivus Life Sciences Ltd share price has increased by 49.80% over the past six months and has increased by 42.55% over the last year.
ALIVUS Stock Price Chart
Alivus Life Sciences Ltd Overview
Market cap₹17,196 Crs
Volume6,235
Prev. Close₹1,400.65
Year range₹830.00 - ₹1,495.30
ISININE03Q201024
About ALIVUS
Alivus Life Sciences is primarily engaged in the development, manufacture, and marketing of active pharmaceutical ingredients.
Alivus Life Sciences Ltd Historical Performance
1 Month Return3.86%
6 Month Return47.61%
3 Year Return123.35%
3 Month Return29.39%
1 Year Return39.56%
5 Year Return102.95%
Alivus Life Sciences Ltd Fundamentals
ROCE(TTM)22.33%
P/E Ratio (TTM)28.51
P/B Ratio5.16
Debt to Equity0.02
ROE16.94%
EPS (TTM)50.64
Dividend Yield0.36%
Book Value271.41
Profit Margin24.00%
Operating Margin29.25%
Alivus Life Sciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,612.24 | 2,421.45 | 2,295.25 | 2,190.18 | 2,137.91 |
| EBITDA | 832.04 | 717.15 | 686.29 | 671.25 | 630.77 |
| Net Profit | 564.48 | 485.63 | 470.89 | 466.96 | 418.72 |
| EPS | 45.99 | 39.63 | 38.43 | 38.11 | 35.63 |
Alivus Life Sciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,380.97 |
| Resistance 1 (R1) | 1,432.87 |
| Pivot Point | 1,413.18 |
Alivus Life Sciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 01-Sep-2026 | 14-May-2026 | 01-Sep-2026 | Final | ₹5.00 |
| 01-Sep-2025 | 15-May-2025 | 01-Sep-2025 | Final | ₹5.00 |
| 17-Oct-2023 | 09-Oct-2023 | 17-Oct-2023 | Interim | ₹22.50 |
| 24-Mar-2023 | 16-Mar-2023 | 24-Mar-2023 | Interim | ₹21.00 |
| 15-Sep-2022 | 21-Apr-2022 | 17-Sep-2022 | Final | ₹10.50 |
ALIVUS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| HIREN KARSANBHAI PATEL | Chairman |
| Yasir Yusufali Rawjee | Managing Director & Chief Executive Officer |
| Vinod Naik | Executive Director / WTD / Head - Technical & Operations |
Alivus Life Sciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,850.00-1.01% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,344.00-0.71% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,916.00-1.09% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Alivus Life Sciences Ltd today is ₹1,371.00 on NSE and ₹1,371.00 on BSE.
- The 52-week high of Alivus Life Sciences Ltd is ₹1,495.30, while the 52-week low is ₹830.00.
- The current market capitalisation of Alivus Life Sciences Ltd is approximately ₹17,196 crore.
- The P/E (Price-to-Earnings) ratio of Alivus Life Sciences Ltd is 28.51. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Alivus Life Sciences Ltd is 5.16. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Alivus Life Sciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ALIVUS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Alivus Life Sciences Ltd has delivered a return of approximately 123.35%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Alivus Life Sciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 74.87% promoters, -0.11% FIIs, 7.18% DIIs, and 10.05% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
